Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives

A series of heterocyclic chloroquine hybrids, containing a chain of two carbon atoms at position four of the quinolinic chain and acting as a link between quinoline and several benzoyl groups, is synthesized and screened in vitro as an inhibitor of β-hematin formation and in vivo for its antimalaria...

Full description

Bibliographic Details
Main Authors: Joyce E. Gutiérrez, Hegira Ramírez, Esteban Fernandez-Moreira, María E. Acosta, Michael R. Mijares, Juan Bautista De Sanctis, Soňa Gurská, Petr Džubák, Marián Hajdúch, Liesangerli Labrador-Fagúndez, Bruno G. Stella, Luis José Díaz-Pérez, Gustavo Benaim, Jaime E. Charris
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/16/12/1709
_version_ 1827573873663541248
author Joyce E. Gutiérrez
Hegira Ramírez
Esteban Fernandez-Moreira
María E. Acosta
Michael R. Mijares
Juan Bautista De Sanctis
Soňa Gurská
Petr Džubák
Marián Hajdúch
Liesangerli Labrador-Fagúndez
Bruno G. Stella
Luis José Díaz-Pérez
Gustavo Benaim
Jaime E. Charris
author_facet Joyce E. Gutiérrez
Hegira Ramírez
Esteban Fernandez-Moreira
María E. Acosta
Michael R. Mijares
Juan Bautista De Sanctis
Soňa Gurská
Petr Džubák
Marián Hajdúch
Liesangerli Labrador-Fagúndez
Bruno G. Stella
Luis José Díaz-Pérez
Gustavo Benaim
Jaime E. Charris
author_sort Joyce E. Gutiérrez
collection DOAJ
description A series of heterocyclic chloroquine hybrids, containing a chain of two carbon atoms at position four of the quinolinic chain and acting as a link between quinoline and several benzoyl groups, is synthesized and screened in vitro as an inhibitor of β-hematin formation and in vivo for its antimalarial activity against chloroquine-sensitive strains of <i>Plasmodium berghei</i> ANKA in this study. The compounds significantly reduced haeme crystallization, with IC<sub>50</sub> values < 10 µM. The values were comparable to chloroquine’s, with an IC<sub>50</sub> of 1.50 ± 0.01 µM. The compounds <b>4c</b> and <b>4e</b> prolonged the average survival time of the infected mice to 16.7 ± 2.16 and 14.4 ± 1.20 days, respectively. We also studied the effect of the compounds <b>4b</b>, <b>4c,</b> and <b>4e</b> on another important human parasite, <i>Leishmania mexicana</i>, which is responsible for cutaneous leishmaniasis, demonstrating a potential leishmanicidal effect against promasigotes, with an IC<sub>50</sub> < 10 µM. Concerning the possible mechanism of action of these compounds on <i>Lesihmania mexicana</i>, we performed experiments demonstrating that these three compounds could induce the collapse of the parasite mitochondrial electrochemical membrane potential (Δφ). The in vitro cytotoxicity assays against mammalian cancerous and noncancerous human cell lines showed that the studied compounds exhibit low cytotoxic effects. The ADME/Tox analysis predicted moderate lipophilicity values, low unbound fraction values, and a poor distribution for these compounds. Therefore, moderate bioavailability was expected. We calculated other molecular descriptors, such as the topological polar surface area, according to Veber’s rules, and except for <b>2</b> and <b>4i</b>, the rest of the compounds violated this descriptor, demonstrating the low antimalarial activity of our compounds in vivo.
first_indexed 2024-03-08T20:27:21Z
format Article
id doaj.art-c3ae8e752e514bfdab501d036bed6509
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-08T20:27:21Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-c3ae8e752e514bfdab501d036bed65092023-12-22T14:31:38ZengMDPI AGPharmaceuticals1424-82472023-12-011612170910.3390/ph16121709Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate DerivativesJoyce E. Gutiérrez0Hegira Ramírez1Esteban Fernandez-Moreira2María E. Acosta3Michael R. Mijares4Juan Bautista De Sanctis5Soňa Gurská6Petr Džubák7Marián Hajdúch8Liesangerli Labrador-Fagúndez9Bruno G. Stella10Luis José Díaz-Pérez11Gustavo Benaim12Jaime E. Charris13Organic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, VenezuelaFacultad de Ciencias de la Salud y Desarrollo Humano, Univesidad Ecotec, Km. 13.5 Samborondón, Guayas, Guayaquil 092302, EcuadorEscuela de Medicina, Universidad Espíritu Santo, Samborondón, Guayas, Guayaquil 092301, EcuadorUnidad de Bioquímica, Facultad de Farmacia, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, VenezuelaBiotechnology Unit, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, VenezuelaInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech RepublicInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech RepublicInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech RepublicInstitute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University, Hněvotínská 1333/5, 779 00 Olomouc, Czech RepublicUnidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, VenezuelaUnidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, VenezuelaUnidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, VenezuelaUnidad de Bioquímica de Parásitos y Señalización Celular, Instituto de Estudios Avanzados (IDEA), Caracas 1080, VenezuelaOrganic Synthesis Laboratory, Faculty of Pharmacy, Central University of Venezuela, Los Chaguaramos 1041-A, Caracas 1040, VenezuelaA series of heterocyclic chloroquine hybrids, containing a chain of two carbon atoms at position four of the quinolinic chain and acting as a link between quinoline and several benzoyl groups, is synthesized and screened in vitro as an inhibitor of β-hematin formation and in vivo for its antimalarial activity against chloroquine-sensitive strains of <i>Plasmodium berghei</i> ANKA in this study. The compounds significantly reduced haeme crystallization, with IC<sub>50</sub> values < 10 µM. The values were comparable to chloroquine’s, with an IC<sub>50</sub> of 1.50 ± 0.01 µM. The compounds <b>4c</b> and <b>4e</b> prolonged the average survival time of the infected mice to 16.7 ± 2.16 and 14.4 ± 1.20 days, respectively. We also studied the effect of the compounds <b>4b</b>, <b>4c,</b> and <b>4e</b> on another important human parasite, <i>Leishmania mexicana</i>, which is responsible for cutaneous leishmaniasis, demonstrating a potential leishmanicidal effect against promasigotes, with an IC<sub>50</sub> < 10 µM. Concerning the possible mechanism of action of these compounds on <i>Lesihmania mexicana</i>, we performed experiments demonstrating that these three compounds could induce the collapse of the parasite mitochondrial electrochemical membrane potential (Δφ). The in vitro cytotoxicity assays against mammalian cancerous and noncancerous human cell lines showed that the studied compounds exhibit low cytotoxic effects. The ADME/Tox analysis predicted moderate lipophilicity values, low unbound fraction values, and a poor distribution for these compounds. Therefore, moderate bioavailability was expected. We calculated other molecular descriptors, such as the topological polar surface area, according to Veber’s rules, and except for <b>2</b> and <b>4i</b>, the rest of the compounds violated this descriptor, demonstrating the low antimalarial activity of our compounds in vivo.https://www.mdpi.com/1424-8247/16/12/1709malarialeishmaniasiscytotoxicityADMETchloroquineaminoalkylbenzoates
spellingShingle Joyce E. Gutiérrez
Hegira Ramírez
Esteban Fernandez-Moreira
María E. Acosta
Michael R. Mijares
Juan Bautista De Sanctis
Soňa Gurská
Petr Džubák
Marián Hajdúch
Liesangerli Labrador-Fagúndez
Bruno G. Stella
Luis José Díaz-Pérez
Gustavo Benaim
Jaime E. Charris
Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
Pharmaceuticals
malaria
leishmaniasis
cytotoxicity
ADMET
chloroquine
aminoalkylbenzoates
title Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
title_full Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
title_fullStr Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
title_full_unstemmed Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
title_short Synthesis, Antimalarial, Antileishmanial, and Cytotoxicity Activities and Preliminary In Silico ADMET Studies of 2-(7-Chloroquinolin-4-ylamino)ethyl Benzoate Derivatives
title_sort synthesis antimalarial antileishmanial and cytotoxicity activities and preliminary in silico admet studies of 2 7 chloroquinolin 4 ylamino ethyl benzoate derivatives
topic malaria
leishmaniasis
cytotoxicity
ADMET
chloroquine
aminoalkylbenzoates
url https://www.mdpi.com/1424-8247/16/12/1709
work_keys_str_mv AT joyceegutierrez synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT hegiraramirez synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT estebanfernandezmoreira synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT mariaeacosta synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT michaelrmijares synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT juanbautistadesanctis synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT sonagurska synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT petrdzubak synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT marianhajduch synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT liesangerlilabradorfagundez synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT brunogstella synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT luisjosediazperez synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT gustavobenaim synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives
AT jaimeecharris synthesisantimalarialantileishmanialandcytotoxicityactivitiesandpreliminaryinsilicoadmetstudiesof27chloroquinolin4ylaminoethylbenzoatederivatives